Arcus Biosciences Logo

Arcus Biosciences

🇺🇸
RCUS
US03969F1093

Arcus Biosciences is a leading US-based biopharmaceutical company specializing in the development of innovative cancer therapies. The firm focuses on researching small-molecule drugs and antibodies to establish new standards in medicine through sophisticated, precision oncology-based approaches.

Next Quarterly Earnings

Tuesday, November 10, 2026
CW 46
After-Hours
In 75 days

After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

Quiet period starts on October 13, 2026

Stock Price

Frequently asked questions

When will Arcus Biosciences report its next quarterly earnings?

Arcus Biosciences is scheduled to report its next quarterly earnings on 11/10/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

When did Arcus Biosciences last report quarterly earnings?

Arcus Biosciences last reported quarterly earnings on 8/5/2026 (Q2 2026). Earnings per share (EPS) came in at -0.72 USD.

How often has Arcus Biosciences beaten expectations?

Arcus Biosciences has beaten analyst EPS estimates in 4 of its last 5 evaluated quarters (beat rate: 80%).

How do I add the Arcus Biosciences earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:-$0.88
Actual:
Q2 2026
Beat
Estimate:-$0.89
Actual:-$0.72
Difference:+$0.17
Q1 2026
Missed
Estimate:-$0.88
Actual:-$1.02
Difference:-$0.14
Price reaction (1 day):-0.2 %
Price reaction (7 days):-4.5 %
Q3 2025
Beat
Estimate:-$1.08
Actual:-$0.89
Difference:+$0.18
Q2 2025
Beat
Estimate:-$1.29
Actual:-$1.27
Difference:+$0.02
Q1 2025
Beat
Estimate:-$1.17
Actual:$0.00
Difference:+$1.17

Earnings statistics

Estimates vs. results

4/5
Quarters above estimates
80%
Beat rate
+0.9%
Avg. EPS surprise

Basis: 5 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
Arcus Biosciences
Ticker Symbol
RCUS
ISIN
US03969F1093
Country
🇺🇸
USA
Sector